<p>We aimed to assess prescribing accuracy, error reduction, usability, and clinician confidence of Ask Eolas (a retrieval-augmented generation-enhanced AI-CDSS) compared to existing antimicrobial guidance tools. We conducted a structured simulation single-site study evaluating Ask Eolas across 45 prescribing cases with healthcare professionals to assess prescribing accuracy. Among 45 participants, Ask Eolas achieved zero prescribing errors versus six and eight documented errors in the two comparator groups (Eolas App and PDF Guidelines), respectively (<i>p</i> &lt; 0.001). The number needed to treat was 1.9 for Ask Eolas versus traditional guidelines, indicating one additional error-free prescription for every two clinicians switching to Ask Eolas. Ask Eolas significantly improved prescribing accuracy while enhancing usability, clinician confidence, and system transparency compared to existing tools. These findings align with TRUST-AI framework principles for safe AI-CDSS deployment, supporting further investigation through real-world implementation studies incorporating live data integration, confidence calibration systems, and comprehensive auditability features in antimicrobial stewardship programmes.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Enhancing quality of antimicrobial prescribing through ‘Ask Eolas’ (language model): a user-testing and simulation evaluation

  • William J. Waldock,
  • Mark Gilchrist,
  • Hutan Ashrafian,
  • Ara Darzi,
  • Bryony Dean Franklin

摘要

We aimed to assess prescribing accuracy, error reduction, usability, and clinician confidence of Ask Eolas (a retrieval-augmented generation-enhanced AI-CDSS) compared to existing antimicrobial guidance tools. We conducted a structured simulation single-site study evaluating Ask Eolas across 45 prescribing cases with healthcare professionals to assess prescribing accuracy. Among 45 participants, Ask Eolas achieved zero prescribing errors versus six and eight documented errors in the two comparator groups (Eolas App and PDF Guidelines), respectively (p < 0.001). The number needed to treat was 1.9 for Ask Eolas versus traditional guidelines, indicating one additional error-free prescription for every two clinicians switching to Ask Eolas. Ask Eolas significantly improved prescribing accuracy while enhancing usability, clinician confidence, and system transparency compared to existing tools. These findings align with TRUST-AI framework principles for safe AI-CDSS deployment, supporting further investigation through real-world implementation studies incorporating live data integration, confidence calibration systems, and comprehensive auditability features in antimicrobial stewardship programmes.